Michael Schmertzler
Director at Ptc Therapeutics, Inc. (PTCT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $6.5M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 9 NewSEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 2,4471,294,147 held (−0%) | $63.38 | $155K | +2.1% |
| Oct 9 NewSEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 531,294,094 held (−0%) | $63.95 | $3K | +1.2% |
| Sep 18SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 2,9941,313,600 held (−0%) | $66.58 | $199K | -2.8% |
| Sep 18SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 7,0061,306,594 held (−1%) | $67.35 | $472K | -3.9% |
| Sep 18SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 9,6241,296,970 held (−1%) | $67.83 | $653K | -4.6% |
| Sep 18SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 3761,296,594 held (−0%) | $68.45 | $26K | -5.5% |
| Sep 11SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 9,4281,327,166 held (−1%) | $67.79 | $639K | -4.6% |
| Sep 11SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 5721,326,594 held (−0%) | $68.67 | $39K | -5.8% |
| Sep 11SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 10,0001,316,594 held (−1%) | $67.34 | $673K | -3.9% |
| Aug 28SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 6,8741,354,720 held (−1%) | $72.74 | $500K | -11.1% |
| Aug 28SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 5,6261,349,094 held (−0%) | $73.18 | $412K | -11.6% |
| Aug 28SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 11,8901,337,204 held (−1%) | $71.55 | $851K | -9.6% |
| Aug 28SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 6101,336,594 held (−0%) | $72.22 | $44K | -10.4% |
| Aug 21SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 5,3351,381,259 held (−0%) | $72.86 | $389K | -11.2% |
| Aug 21SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 7,1651,374,094 held (−1%) | $73.67 | $528K | -12.2% |
| Aug 21SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 9,4191,364,675 held (−1%) | $70.78 | $667K | -8.6% |
| Aug 21SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 2,3901,362,285 held (−0%) | $71.88 | $172K | -10.0% |
| Aug 21SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 6911,361,594 held (−0%) | $72.92 | $50K | -11.3% |
- Sell
Director Michael Schmertzler sold $155K of PTCT at $63.38 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Michael Schmertzler sold $3K of PTCT at $63.95 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Michael Schmertzler sold $199K of PTCT at $66.58 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Michael Schmertzler sold $472K of PTCT at $67.35 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Michael Schmertzler sold $653K of PTCT at $67.83 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Michael Schmertzler sold $26K of PTCT at $68.45 — pre-scheduled 10b5-1 plan sale.